default author photo

Xiang Li

Government of the People's Republic of China - Department of Molecular Biology and Immunology

China

SCHOLARLY PAPERS

2

DOWNLOADS

206

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Efficacy Analysis of Nivolumab in Combination with Gemcitabine and Cisplatin in Patients with Unresectable or Metastatic Biliary Tract Cancers

Number of pages: 75 Posted: 28 Oct 2019
Kaichao Feng, Yang Liu, Qingming Yang, Liang Dong, Jiejie Liu, Xiang Li, Qian Mei and Weidong Han
Government of the People's Republic of China - Department of Bio-Therapeutic, Government of the People's Republic of China - Department of Bio-Therapeutic, Government of the People's Republic of China - Department of Bio-Therapeutic, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology and Government of the People's Republic of China - Department of Molecular Biology and Immunology
Downloads 111 (635,507)

Abstract:

Loading...

Biliary tract cancers; Nivolumab; Gemcitabine; Combination therapy

2.

Nivolumab in Combination with Gemcitabine and Cisplatin for Advanced Unresectable or Metastatic Biliary Tract Cancers: Results from a Single Center, Single-Arm, Phase I Study

Number of pages: 77 Posted: 07 Jun 2019
Kaichao Feng, Qian Mei, Yang Liu, Qingming Yang, Liang Dong, Jiejie Liu, Xiang Li and Weidong Han
Government of the People's Republic of China - Department of Bio-Therapeutic, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Department of Bio-Therapeutic, Government of the People's Republic of China - Department of Bio-Therapeutic, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology and Zhejiang University - Department of Medical Oncology
Downloads 95 (715,072)

Abstract:

Loading...

Nivolumab; Gemcitabine; advanced unresectable or metastatic biliary tract cancers; PD-1; immune checkpoint inhibitor